179 related articles for article (PubMed ID: 25958017)
1. 5,6-δ-DHTL, a stable metabolite of arachidonic acid, is a potential substrate for paraoxonase 1.
Eryanni-Levin S; Khatib S; Levy-Rosenzvig R; Tamir S; Szuchman-Sapir A
Biochim Biophys Acta; 2015 Sep; 1851(9):1118-22. PubMed ID: 25958017
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase 1 in endothelial cells impairs vasodilation induced by arachidonic acid lactone metabolite.
Gilad D; Atiya S; Mozes-Autmazgin Z; Ben-Shushan RS; Ben-David R; Amram E; Tamir S; Chuyun D; Szuchman-Sapir A
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):386-393. PubMed ID: 30572120
[TBL] [Abstract][Full Text] [Related]
3. 5,6-δ-DHTL, a stable metabolite of arachidonic acid, is a potential EDHF that mediates microvascular dilation.
Levi-Rosenzvig R; Beyer AM; Hockenberry J; Ben-Shushan RS; Chuyun D; Atiya S; Tamir S; Gutterman DD; Szuchman-Sapir A
Free Radic Biol Med; 2017 Feb; 103():87-94. PubMed ID: 28007573
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 1 hydrolysis of EPA-derived lactone impairs endothelial-mediated vasodilation.
Pinhas S; Amram E; Slutsky-Smith E; Ertracht O; Atar S; Chuyun D; Szuchman-Sapir A
Prostaglandins Other Lipid Mediat; 2022 Oct; 162():106665. PubMed ID: 35817276
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid.
Gamliel-Lazarovich A; Abassi Z; Khatib S; Tavori H; Vaya J; Aviram M; Keidar S
Atherosclerosis; 2012 May; 222(1):92-8. PubMed ID: 22365750
[TBL] [Abstract][Full Text] [Related]
6. Identification of biologically active δ-lactone eicosanoids as paraoxonase substrates.
Teiber JF; Xiao J; Kramer GL; Ogawa S; Ebner C; Wolleb H; Carreira EM; Shih DM; Haley RW
Biochem Biophys Res Commun; 2018 Oct; 505(1):87-92. PubMed ID: 30241945
[TBL] [Abstract][Full Text] [Related]
7. Lyso-DGTS lipid isolated from microalgae enhances PON1 activities in vitro and in vivo, increases PON1 penetration into macrophages and decreases cellular lipid accumulation.
Dahli L; Atrahimovich D; Vaya J; Khatib S
Biofactors; 2018 May; 44(3):299-310. PubMed ID: 29659105
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of arachidonic acid to epoxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and prostaglandins in cultured rat hippocampal astrocytes.
Amruthesh SC; Boerschel MF; McKinney JS; Willoughby KA; Ellis EF
J Neurochem; 1993 Jul; 61(1):150-9. PubMed ID: 8515261
[TBL] [Abstract][Full Text] [Related]
9. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
Gauthier KM; Olson L; Harder A; Isbell M; Imig JD; Gutterman DD; Falck JR; Campbell WB
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F765-72. PubMed ID: 21753077
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase.
Widstrom RL; Norris AW; Van Der Veer J; Spector AA
Biochemistry; 2003 Oct; 42(40):11762-7. PubMed ID: 14529287
[TBL] [Abstract][Full Text] [Related]
11. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
[TBL] [Abstract][Full Text] [Related]
12. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
13. Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids.
Weintraub NL; Fang X; Kaduce TL; VanRollins M; Chatterjee P; Spector AA
Am J Physiol; 1999 Nov; 277(5):H2098-108. PubMed ID: 10564166
[TBL] [Abstract][Full Text] [Related]
14. The uptake mechanism and intracellular fate of Paraoxonase-1 in endothelial cells.
Raz BD; Dimitry C; Andrea SS
Free Radic Biol Med; 2020 Jun; 153():26-33. PubMed ID: 32244050
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 metabolites of arachidonic acid: rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells.
Fang X; Kaduce TL; Weintraub NL; Spector AA
Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):367-71. PubMed ID: 9430380
[TBL] [Abstract][Full Text] [Related]
16. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.
Khersonsky O; Tawfik DS
Biochemistry; 2005 Apr; 44(16):6371-82. PubMed ID: 15835926
[TBL] [Abstract][Full Text] [Related]
17. Human carotid plaque phosphatidylcholine specifically interacts with paraoxonase 1, increases its activity, and enhances its uptake by macrophage at the expense of its binding to HDL.
Cohen E; Aviram M; Khatib S; Artoul F; Rabin A; Mannheim D; Karmeli R; Salamon T; Vaya J
Free Radic Biol Med; 2014 Nov; 76():14-24. PubMed ID: 25091896
[TBL] [Abstract][Full Text] [Related]
18. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
[TBL] [Abstract][Full Text] [Related]
19. Mouse serum paraoxonase-1 lactonase activity is specific for medium-chain length fatty acid lactones.
Connelly PW; Picardo CM; Potter PM; Teiber JF; Maguire GF; Ng DS
Biochim Biophys Acta; 2011 Jan; 1811(1):39-45. PubMed ID: 21044894
[TBL] [Abstract][Full Text] [Related]
20. High potassium intake enhances the inhibitory effect of 11,12-EET on ENaC.
Sun P; Lin DH; Yue P; Jiang H; Gotlinger KH; Schwartzman ML; Falck JR; Goli M; Wang WH
J Am Soc Nephrol; 2010 Oct; 21(10):1667-77. PubMed ID: 20595684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
